$3.01
0.196.74%
In chiusura: -
$2.90
-0.11-3.65%
After hour: 4:09 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Alector. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Alector.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Alector Inc addetti ai lavori?
A Alector Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 110.95K azioni del valore di $275.07K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno giugno 23, 2025, Kristine Yaffe, l'azienda - sold 1K condivisioni per $1.44 ciascuna.
- Il giorno settembre 4, 2025, Grace Wong-Sarad, l'azienda PRINCIPAL ACCOUNTING OFFICER sold 5.91K condivisioni per $2.5 ciascuna.
- Il giorno agosto 27, 2025, Paula Hammond, l'azienda - sold 14K condivisioni per $2.36 ciascuna.
Statistiche sulla proprietà per Alector Inc
Numero di azioni emesse
101.212M
Azioni possedute dagli insider
9.168M
Percentuale posseduta dagli Insider
9.06%
Azioni possedute dagli investitori istituzionali
39.281M
Percentuale posseduta dagli investitori istituzionali
38.8%
Sep 04, 2025 | PRINCIPAL ACCOUNTING OFFICER | -5.91K | $2.50 | -$14.76K | SELL | -5.40% | 103.45K | Sep 02 | ||
Sep 04, 2025 | PRINCIPAL FINANCIAL OFFICER | -15.84K | $2.50 | -$39.55K | SELL | -4.37% | 346.57K | Sep 02 | ||
Sep 04, 2025 | PRESIDENT AND HEAD R&D | -23.64K | $2.50 | -$59.02K | SELL | -4.17% | 543.34K | Sep 02 | ||
Sep 04, 2025 | CHIEF EXECUTIVE OFFICER | -51.56K | $2.50 | -$128.74K | SELL | -1.69% | 3.00M | Sep 02 | ||
Aug 27, 2025 | — | -14.00K | $2.36 | -$33.00K | SELL | -15.75% | 74.91K | Aug 26 | ||
Jun 23, 2025 | — | -1.00K | $1.44 | -$1.44K | SELL | -1.04% | 95.41K | Jun 20 | ||
Jun 04, 2025 | CHIEF FINANCIAL OFFICER | -16.49K | $1.34 | -$22.07K | SELL | -5.28% | 296.07K | Jun 02 | ||
Jun 04, 2025 | PRESIDENT AND HEAD R&D | -23.89K | $1.34 | -$31.97K | SELL | -4.46% | 512.25K | Jun 02 | ||
Jun 04, 2025 | CHIEF EXECUTIVE OFFICER | -52.09K | $1.34 | -$69.71K | SELL | -1.67% | 3.07M | Jun 02 | ||
Mar 05, 2025 | PRESIDENT AND HEAD R&D | -29.07K | $1.47 | -$42.66K | SELL | -5.14% | 536.14K | Mar 03 | ||
Mar 05, 2025 | CHIEF EXECUTIVE OFFICER | -40.33K | $1.47 | -$59.18K | SELL | -1.28% | 3.12M | Mar 03 | ||
Mar 05, 2025 | CHIEF FINANCIAL OFFICER | -18.09K | $1.47 | -$26.55K | SELL | -5.47% | 312.56K | Mar 03 | ||
Mar 05, 2025 | CHIEF MEDICAL OFFICER | -16.31K | $1.47 | -$23.93K | SELL | -4.67% | 332.98K | Mar 03 | ||
Dec 03, 2024 | CHIEF FINANCIAL OFFICER | -16.49K | $2.52 | -$41.54K | SELL | -4.75% | 330.65K | Dec 02 | ||
Dec 03, 2024 | CHIEF EXECUTIVE OFFICER | -52.17K | $2.52 | -$131.44K | SELL | -1.62% | 3.16M | Dec 02 | ||
Dec 03, 2024 | CHIEF MEDICAL OFFICER | -14.89K | $2.52 | -$37.52K | SELL | -4.09% | 349.28K | Dec 02 | ||
Dec 03, 2024 | PRESIDENT AND HEAD R&D | -26.50K | $2.52 | -$66.76K | SELL | -4.48% | 565.22K | Dec 02 | ||
Sep 04, 2024 | CHIEF FINANCIAL OFFICER | -7.30K | $4.88 | -$35.62K | SELL | -5.29% | 130.74K | Sep 03 | ||
Sep 04, 2024 | CHIEF EXECUTIVE OFFICER | -26.50K | $4.88 | -$129.39K | SELL | -1.01% | 2.60M | Sep 03 | ||
Sep 04, 2024 | PRESIDENT AND HEAD R&D | -13.93K | $4.88 | -$67.98K | SELL | -4.56% | 291.71K | Sep 03 | ||
Sep 04, 2024 | CHIEF MEDICAL OFFICER | -8.48K | $4.88 | -$41.39K | SELL | -4.50% | 179.79K | Sep 03 | ||
Aug 23, 2024 | — | -44.25K | $5.16 | -$228.39K | SELL | -55.84% | 35.00K | Aug 22 | ||
Aug 13, 2024 | — | -10.50K | $5.06 | -$53.18K | SELL | -14.85% | 60.21K | Aug 12 | ||
Aug 13, 2024 | — | -5.00K | $5.06 | -$25.31K | SELL | -6.88% | 67.71K | Aug 12 | ||
Jun 04, 2024 | CHIEF MEDICAL OFFICER | -8.04K | $4.80 | -$38.58K | SELL | -4.10% | 188.27K | Jun 03 | ||
Jun 04, 2024 | PRESIDENT AND HEAD R&D | -13.21K | $4.80 | -$63.37K | SELL | -4.14% | 305.64K | Jun 03 | ||
Jun 04, 2024 | CHIEF EXECUTIVE OFFICER | -25.14K | $4.80 | -$120.62K | SELL | -0.95% | 2.63M | Jun 03 | ||
Jun 04, 2024 | CHIEF FINANCIAL OFFICER | -6.92K | $4.80 | -$33.21K | SELL | -4.77% | 138.04K | Jun 03 | ||
Mar 05, 2024 | CHIEF FINANCIAL OFFICER | -5.72K | $6.92 | -$39.56K | SELL | -3.79% | 144.96K | Mar 04 | ||
Mar 05, 2024 | CHIEF EXECUTIVE OFFICER | -18.84K | $6.92 | -$130.39K | SELL | -0.71% | 2.65M | Mar 04 | ||
Mar 05, 2024 | CHIEF MEDICAL OFFICER | -6.00K | $6.92 | -$41.55K | SELL | -2.97% | 196.31K | Mar 04 | ||
Mar 05, 2024 | PRESIDENT AND HEAD R&D | -10.17K | $6.92 | -$70.39K | SELL | -3.09% | 318.85K | Mar 04 | ||
Dec 06, 2023 | CHIEF FINANCIAL OFFICER | -4.57K | $5.56 | -$25.43K | SELL | -2.95% | 150.67K | Dec 04 | ||
Dec 06, 2023 | CHIEF MEDICAL OFFICER | -5.04K | $5.56 | -$27.99K | SELL | -2.43% | 202.31K | Dec 04 | ||
Dec 06, 2023 | CHIEF EXECUTIVE OFFICER | -23.83K | $5.56 | -$132.50K | SELL | -0.88% | 2.67M | Dec 04 | ||
Dec 06, 2023 | PRESIDENT AND HEAD R&D | -12.52K | $5.56 | -$69.61K | SELL | -3.67% | 329.02K | Dec 04 | ||
Sep 13, 2023 | 10% OWNER | -500.00K | $6.00 | -$3.00M | SELL | -4.40% | 10.85M | Sep 11 | ||
Sep 13, 2023 | DIRECTOR | -500.00K | $6.00 | -$3.00M | SELL | -4.39% | 10.89M | Sep 11 | ||
Sep 06, 2023 | CHIEF EXECUTIVE OFFICER | -5.65K | $5.19 | -$29.33K | SELL | -0.25% | 2.30M | Sep 05 | ||
Sep 06, 2023 | PRESIDENT AND HEAD R&D | -6.21K | $5.19 | -$32.28K | SELL | -3.37% | 177.94K | Sep 05 | ||
Sep 06, 2023 | CHIEF MEDICAL OFFICER | -2.77K | $5.19 | -$14.39K | SELL | -2.71% | 99.35K | Sep 05 | ||
Sep 06, 2023 | CHIEF FINANCIAL OFFICER | -1.11K | $5.19 | -$5.79K | SELL | -3.34% | 32.25K | Sep 05 | ||
Jun 05, 2023 | PRESIDENT AND HEAD R&D | -4.09K | $6.90 | -$28.25K | SELL | -2.17% | 184.15K | Jun 02 | ||
Jun 05, 2023 | CHIEF FINANCIAL OFFICER | -1.05K | $6.90 | -$7.25K | SELL | -3.05% | 33.36K | Jun 02 | ||
Jun 05, 2023 | CHIEF MEDICAL OFFICER | -2.62K | $6.90 | -$18.07K | SELL | -2.50% | 102.12K | Jun 02 | ||
Jun 05, 2023 | CHIEF EXECUTIVE OFFICER | -5.25K | $6.90 | -$36.28K | SELL | -0.23% | 2.30M | Jun 02 | ||
Mar 21, 2023 | CHIEF EXECUTIVE OFFICER | 27.80K | $6.22 | -$94.43K | GRANT | 1.22% | 2.31M | Mar 03 - Mar 17 | ||
Mar 03, 2023 | CHIEF MEDICAL OFFICER | -5.38K | $8.47 | -$45.61K | SELL | -4.89% | 104.74K | Dec 02 - Mar 02 | ||
Mar 03, 2023 | PRESIDENT AND HEAD R&D | -10.12K | $8.32 | -$84.22K | SELL | -5.10% | 188.24K | Mar 02 | ||
Mar 03, 2023 | CHIEF FINANCIAL OFFICER | -1.29K | $8.32 | -$10.74K | SELL | -3.62% | 34.41K | Mar 02 | ||
Mar 03, 2023 | CHIEF EXECUTIVE OFFICER | -5.85K | $8.32 | -$48.65K | SELL | -0.26% | 2.28M | Mar 02 | ||
Sep 07, 2022 | CHIEF MEDICAL OFFICER | -2.18K | $10.62 | -$23.12K | SELL | -2.36% | 90.07K | Sep 02 | ||
Sep 07, 2022 | CHIEF DEVELOPMENT OFFICER | -176.00 | $10.62 | -$1.87K | SELL | -0.03% | 529.29K | Sep 02 | ||
Jun 06, 2022 | CHIEF DEVELOPMENT OFFICER | -177.00 | $8.71 | -$1.54K | SELL | -0.03% | 529.47K | Jun 02 | ||
Mar 03, 2022 | CHIEF DEVELOPMENT OFFICER | -287.00 | $15.57 | -$4.47K | SELL | -0.05% | 528.40K | Mar 01 | ||
Dec 14, 2021 | PRESIDENT AND COO | 0.00 | $19.37 | -$640.82K | SELL-OPTIONS | 0.00% | 102.60K | Dec 10 - Dec 13 | ||
Dec 10, 2021 | PRESIDENT AND COO | 0.00 | $18.73 | -$1.22M | SELL-OPTIONS | 0.00% | 102.60K | Dec 08 - Dec 09 | ||
Dec 03, 2021 | CHIEF DEVELOPMENT OFFICER | -250.00 | $20.09 | -$5.02K | SELL | -0.05% | 528.69K | Dec 01 | ||
Nov 12, 2021 | CHIEF EXECUTIVE OFFICER | -110.00K | $25.00 | -$2.75M | SELL | -3.11% | 3.43M | Nov 10 - Nov 11 | ||
Nov 10, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.00 | -$5.00M | SELL | -8.67% | 2.11M | Nov 08 - Nov 09 | ||
Nov 08, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.00 | -$5.00M | SELL | -8.56% | 2.14M | Nov 04 - Nov 05 | ||
Sep 23, 2021 | CHIEF EXECUTIVE OFFICER | -109.63K | $25.31 | -$2.77M | SELL | -3.51% | 3.02M | Sep 22 - Sep 23 | ||
Sep 22, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.96 | -$5.19M | SELL | -6.02% | 3.13M | Sep 20 - Sep 21 | ||
Aug 11, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $18.93 | -$378.52K | SELL-OPTIONS | 0.00% | 234.32K | Aug 09 | ||
Aug 09, 2021 | DIRECTOR | -9.98K | $19.17 | -$1.30M | SELL | -100.00% | 0.00 | Jul 02 - Aug 05 | ||
Jul 08, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $26.33 | -$1.39M | SELL-OPTIONS | 0.00% | 234.32K | Jul 06 - Jul 07 | ||
Jul 07, 2021 | VICE PRESIDENT, FINANCE | -50.00K | $22.96 | -$2.90M | SELL | -39.47% | 76.69K | Jul 02 - Jul 06 | ||
Jul 07, 2021 | CHIEF DEVELOPMENT OFFICER | 0.00 | $20.14 | -$1.32M | SELL-OPTIONS | 0.00% | 522.32K | Jul 02 | ||
Jul 06, 2021 | CHIEF MEDICAL OFFICER | -39.40K | $22.05 | -$1.23M | SELL | -14.39% | 234.32K | Jul 01 - Jul 02 | ||
Jun 21, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $15.62 | -$447.02K | SELL-OPTIONS | 0.00% | 273.72K | Jun 15 - Jun 16 | ||
Jun 10, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.28 | -$187.75K | SELL-OPTIONS | 0.00% | 273.72K | Jun 08 | ||
Jun 03, 2021 | VICE PRESIDENT, FINANCE | -1.84K | $17.77 | -$32.77K | SELL | -1.43% | 126.69K | Jun 02 | ||
May 25, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.20 | -$147.93K | SELL-OPTIONS | 0.00% | 273.72K | May 21 | ||
May 20, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.41 | -$38.94K | SELL-OPTIONS | 0.00% | 273.72K | May 18 | ||
Apr 08, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.40 | -$213.86K | SELL-OPTIONS | 0.00% | 213.72K | Apr 07 | ||
Mar 24, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $15.45 | -$638.47K | SELL-OPTIONS | 0.00% | 213.72K | Mar 22 - Mar 23 | ||
Mar 10, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.25 | -$186.81K | SELL-OPTIONS | 0.00% | 213.72K | Mar 09 | ||
Feb 11, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.59 | -$238.46K | SELL-OPTIONS | 0.00% | 213.72K | Feb 09 | ||
Jan 27, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.19 | -$551.76K | SELL-OPTIONS | 0.00% | 213.72K | Jan 25 - Jan 26 | ||
Jan 21, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.23 | -$374.81K | SELL-OPTIONS | 0.00% | 213.72K | Jan 19 - Jan 20 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.